Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 11 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 3

1(20.0%)

Phase 2

1(20.0%)

5Total

N/A(3)

Phase 3(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT07551960Not ApplicableEnrolling By Invitation

Pilot Validation of the STELA Preventive Medicine Platform to Reduce Modifiable Health Risk Factors in Adults (CPM-STELA)

Role: lead

NCT07551947Enrolling By Invitation

Insulin Resistance as a Predictor of Pulsed Field Ablation Success in Atrial Fibrillation (HOMA-PULSE)

Role: lead

NCT07433309Not Yet Recruiting

CT Body Composition as Predictor of Exercise Therapy Outcome in Peripheral Arterial Disease

Role: lead

NCT07103317Recruiting

Comprehensive Coronary Physiology in Patients With Angina With Nonobstructive Coronary Arteries - Czech Republic

Role: collaborator

NCT05717725Phase 3Recruiting

Pulsed-field Ablation Vs. Sham Ablation to Treat AF

Role: collaborator

NCT06539416Recruiting

Mixed Reality in MitraClip Implantation: Preliminary Case Series

Role: lead

NCT06707506Completed

Atrial Fibrillation Risk After Miniinvasive Mitral Valve Repair

Role: lead

NCT05600751Not ApplicableUnknown

Radiosurgery of Ganglion StELlatum In Patients With REFractory Angina Pectoris

Role: collaborator

NCT06166524Phase 2Unknown

Pulsed-field Ablation for Patients With Asymptomatic Non-paroxysmal Atrial Fibrillation

Role: collaborator

NCT05148923Not ApplicableCompleted

Comparison of Two DCCV Algorithms - Rational Versus Maximum Fixed Energy

Role: lead

NCT05672160Completed

Overal Survival After TAVI According to Sarcopenia

Role: lead

All 11 trials loaded